|
|
|
Volumn 23, Issue 4 SUPPL. 9, 1996, Pages 21-27
|
|
Aromatase inhibitors: Rationale for use following antiestrogen therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLUTETHIMIDE;
ANTIESTROGEN;
AROMATASE INHIBITOR;
ESTROGEN;
FADROZOLE;
FORMESTANE;
TAMOXIFEN;
ANIMAL CELL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG POTENCY;
FEMALE;
HORMONAL REGULATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MOUSE;
NONHUMAN;
OVARIECTOMY;
POSTMENOPAUSE;
PRIORITY JOURNAL;
REPRODUCIBILITY;
REVIEW;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ESTRADIOL;
ESTROGENS;
FEMALE;
HUMANS;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, NUDE;
NEOPLASMS, HORMONE-DEPENDENT;
TAMOXIFEN;
TUMOR CELLS, CULTURED;
|
|
EID: 0029741056
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (21)
|
|
References (0)
|
